SCHEMBL4557331

SCHEMBL4557331

CCOC(CCl)(C(N)=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
HTT P42858 1/20 0.38
CYP2D6 P10635 2/20 0.37
CYP3A4 P08684 1/20 0.37
TSHR P16473 1/20 0.37
KCNN4 O15554 5/20 0.37
LMNA P02545 2/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
CHRM3 P20309 1/20 0.36
KCNH2 Q12809 1/20 0.36
CYP2C19 P33261 1/20 0.36
HIF1A Q16665 1/20 0.36
KDM4E B2RXH2 1/20 0.35
CTDSP1 Q9GZU7 1/20 0.35
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
CYP1A2 P05177 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5138481 0.98 MAPT (0.43) MAPTKMT2AHTTCYP2D6CYP3A4
SCHEMBL5509050 0.84 MAPT (0.44) MAPTKMT2AHTTCYP2D6CYP3A4
SCHEMBL9667392 0.81 KIF11 (0.44) MAPTKMT2AHTTCYP2D6CYP3A4
SCHEMBL27592432 0.77 TAAR1 (0.41) MAPTKMT2ACYP2D6CYP3A4KCNN4
SCHEMBL20293767 0.77 MAPT (0.47) MAPTKMT2AHTTCYP2D6CYP3A4
SCHEMBL8938100 0.76 MAPT (0.50) MAPTKMT2AHTTCYP2D6CYP3A4
SCHEMBL4561507 0.76 CYP2D6 (0.50) MAPTKMT2AHTTCYP2D6CYP3A4
SCHEMBL17653676 0.76 CYP2D6 (0.43) MAPTKMT2ACYP2D6CYP3A4TSHR
SCHEMBL17653674 0.76 CYP2D6 (0.43) MAPTKMT2ACYP2D6CYP3A4TSHR
SCHEMBL6179245 0.76 MAPT (0.40) MAPTKMT2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008096119-A1 SALTS 669 ASTRAZENECA AB (SE) 2008-08-14 WO claimed
EP-2124941-A1 COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST Argenta Discovery Limited (GB) 2009-12-02 EP disclosed
WO-2008096126-A1 COMBINATION OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2-ADRENOCEPTOR AGONIST ARGENTA DISCOVERY LTD (GB) 2008-08-14 WO disclosed